About Predicine
Predicine is a global molecular insights company that is committed to advancing precision medicine in oncology and infectious diseases. Predicine has developed a breakthrough cell-free DNA- and cell-free RNA-based liquid biopsy technology enabling minimally invasive molecular diagnosis for treatment selection, therapy monitoring, and minimal residual disease and early cancer detection. The company has launched a portfolio of blood-, urine- and tissue-based diagnostic assays for oncology and infectious diseases, including COVID-19. Through its business operations in Silicon Valley, Houston, Shanghai, Singapore, Berlin and Boston, Predicine partners with leading biopharma companies, institutions and governments to support personalized healthcare on a global scale.
|
|
|
51-200 employees
View all Predicine employees
|
|
Biotechnology
|
|
3555 Arden Road,Hayward,CA,US
|
|
2015
|
|
Oncology, Precision Medicine, Infectious Diseases, Clinical Trial, Biomarker, Non-Invasive Cancer Diagnostics, Precision Diagnostics, Liquid Biopsy, Covid-19, Mrd
|
Predicine Alternatives
Frequently Asked Questions about Predicine
Shidong Jia is the CEO of Predicine. To contact Shidong Jia email at [email protected]. Or you may call +1.6176971433
Predicine Staff Directory
Search Predicine Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
